Atanu Chandra

Atanu Chandra

Auto-generated profile, based on publicly available information

Atanu Chandra

Department of Internal Medicine, Calcutta National Medical College , Kolkata

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2021 in Postgraduate Medical Journal
Verified
Journal Article
Open access
PDF file
ACAtanu Chandra
Atanu Chandra
UCUDDALAK CHAKRABORTY
UDDALAK CHAKRABORTY
SGShrestha Ghosh
Shrestha Ghosh
SDSugata Dasgupta
Sugata Dasgupta
Rising incidence of thromboembolism secondary to COVID-19 has become a global concern, with several surveys reporting increased mortality rates. Thrombogenic potential of the SARS-CoV-2 virus has been hypothesised to originate from its ability to produce an exaggerated inflammatory response leading to endothelial dysfunction. Anticoagulants have remained the primary modality of treatment of thromboembolism for decades. However, there is no universal consensus regarding the timing, dosage and duration of anticoagulation in COVID-19 as well as need for postdischarge prophylaxis. This article seeks to review the present guidelines and recommendations as well as the ongoing trials on use of anticoagulants in COVID-19, identify discrepancies between all these, and provide a comprehensive strategy regarding usage of these drugs in the current pandemic.

25 August 2020 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
UCUddalak Chakraborty
Uddalak Chakraborty
ACAtanu Chandra
Atanu Chandra
ARAritra Kumar Ray
Aritra Kumar Ray
PBPurbasha Biswas
Purbasha Biswas
SARS-CoV-2 has wreaked havoc globally and has claimed innumerable lives all over the world. Apart from the characteristic respiratory illness, this disease has been associated with florid extrapulmonary manifestations and complications. A 59-year-old female healthcare worker presented with features of acute-onset non-compressive myelopathy with a sensory level at T10 segment along with high-grade fever for 4 days. MRI of dorsal spine was suggestive of myelitis at T7 vertebral level. She was initiated on injectable steroids and did show some initial signs of recovery. A day later, she developed an acute-onset respiratory failure but could not be revived despite our best efforts. Her nasopharyngeal and oropharyngeal swab turned out to be positive for SARS-CoV-2 reverse transcriptase polymerase chain reaction (RT-PCR). We hereby report a case of acute transverse myelitis with COVID-19 as a probable aetiology.

18 December 2020 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
UCUddalak Chakraborty
Uddalak Chakraborty
SGShrestha Ghosh
Shrestha Ghosh
ACAtanu Chandra
Atanu Chandra
ARAritra Kumar Ray
Aritra Kumar Ray
The SARS-CoV-2 has wreaked havoc globally and has claimed innumerable lives all over the world. The symptoms of this disease may range from mild influenza-like symptoms to severe acute respiratory distress syndrome with high morbidity and mortality. With improved diagnostic techniques and better disease understanding, an increased number of cases are being reported with extrapulmonary manifestations of this disease ranging from renal and gastrointestinal to cardiac, hepatic, neurological and haematological dysfunction. Subacute thyroiditis is a self-limiting and painful thyroid gland inflammation most often secondary to viral infections. We report a case of subacute thyroiditis in a 58-year-old gentleman presenting with a painful swelling in the neck who was subsequently detected to be positive for SARS-CoV-2. We seek to highlight the broad clinical spectrum of the COVID-19 by reporting probably the first case of subacute thyroiditis possibly induced by SARS-CoV-2 infection from India.

7 September 2020 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
ACAtanu Chandra
Atanu Chandra
UCUddalak Chakraborty
Uddalak Chakraborty
JPJyotirmoy Pal
Jyotirmoy Pal
PKParthasarathi Karmakar
Parthasarathi Karmakar
COVID-19 caused by SARS-CoV-2 may present with a wide spectrum of symptoms ranging from mild upper respiratory tract infection like illness to severe pneumonia and death. Patients may have severe hypoxaemia without proportional features of respiratory distress, also known as ‘silent’ or ‘apathetic’ hypoxia. We present a case of a 56-year-old man with COVID-19 who presented to the fever clinic of our institution with fever and cough without any respiratory distress but low oxygen saturation. The patient deteriorated over the next 2 days but eventually recovered of his illness in due course of time. This case demonstrates ‘silent hypoxia’ as a possible presentation in COVID-19 and emphasises the importance of meticulous clinical examination including oxygen saturation measurements in suspected or confirmed patients.

22 February 2024 in The American Journal of Medicine
Verified
Journal Article
Closed access
ACAtanu Chandra
Atanu Chandra
SDSugata Dasgupta
Sugata Dasgupta

11 November 2021 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
ACAtanu Chandra
Atanu Chandra
KSKoustav Ali Shah
Koustav Ali Shah
SMShubhashis Mahato
Shubhashis Mahato
MBMoni Sankar Bhattacharjee
Moni Sankar Bhattacharjee
TMTanuka Mandal
Tanuka Mandal